Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

185 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Completed

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

NCT01013649

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +14 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 689 locations
View Trial Details
Completed

Pancreatic Adenocarcinoma Signature Stratification for Treatment

NCT04469556

Conditions
Advanced Pancreatic Cancer, Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma
Locations
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health New Hyde Park, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

NCT03727880

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • Samuel Oschin Cancer Center at Cedars-Sinai Los Angeles, California, United States
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • The University of Texas Health Science Center San Antonio San Antonio, Texas, United States
View Trial Details
Completed

Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

NCT05641896

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +23 more
Locations
  • University of California Los Angeles (UCLA) Health Los Angeles, California, United States
  • Massachusetts general hospital Boston, Massachusetts, United States
  • BAMF Health Grand Rapids, Michigan, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma

NCT04752696

Conditions
Pancreatic Ductal Adenocarcinoma
Locations
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • University of Kansas Medical Center Westwood, Kansas, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

NCT04257448

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Uniklinik Köln Cologne, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin Göttingen Göttingen, Germany
View Trial Details
Completed

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

NCT04853017

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +57 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details

Related conditions